<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2024-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:kwm="http://kwavemedia.com/20241231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="kwm-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-06-222023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
        </entity>
        <period>
            <startDate>2023-06-22</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-21_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-21</instant>
        </period>
    </context>
    <context id="AsOf2023-06-21_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-21</instant>
        </period>
    </context>
    <context id="AsOf2023-06-21_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-21</instant>
        </period>
    </context>
    <context id="AsOf2023-06-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
        </entity>
        <period>
            <instant>2023-06-21</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2023-06-222023-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-22</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-06-222023-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-22</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-06-222023-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-22</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_GlobalStarMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">kwm:GlobalStarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_KEnterMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">kwm:KEnterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-31_custom_FiveInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">kwm:FiveInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-01-31_custom_FiveInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002000756</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">kwm:FiveInvestorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000004">0002000756</dei:EntityCentralIndexKey>
    <ifrs-full:Revenue
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0071"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="From2023-06-222023-12-31"
      id="xdx2ixbrl0072"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:OperatingExpense
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0080"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0083"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0086"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0089"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0100"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0102"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-21_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0108"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-21_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-21_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0110"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2023-06-21"
      id="xdx2ixbrl0111"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-06-21_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0113"
      unitRef="Shares"
      xsi:nil="true"/>
    <kwm:SharesIssuedForRelatedPartyReceivable
      contextRef="From2023-06-222023-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0116"
      unitRef="USD"
      xsi:nil="true"/>
    <kwm:SharesIssuedForRelatedPartyReceivable
      contextRef="From2023-06-222023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0117"
      unitRef="USD"
      xsi:nil="true"/>
    <kwm:OtherReserve
      contextRef="From2023-06-222023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <kwm:OtherReserve
      contextRef="From2023-06-222023-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0124"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-06-222023-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0127"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2023-06-222023-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0128"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0146"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0147"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0148"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0149"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0161"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0170"
      unitRef="USD"
      xsi:nil="true"/>
    <kwm:IncreaseDecreaseInOtherPayablesRelatedPartiesOtherPayablesRelatedParties
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0173"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0176"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2023-06-222023-12-31"
      id="xdx2ixbrl0177"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0182"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2023-06-222023-12-31"
      id="xdx2ixbrl0183"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0188"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2023-06-222023-12-31"
      id="xdx2ixbrl0189"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0191"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-06-21"
      id="xdx2ixbrl0192"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0194"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2023-12-31"
      id="xdx2ixbrl0195"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0226"
      unitRef="USD"
      xsi:nil="true"/>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0240"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2024-01-01to2024-12-31"
      id="xdx2ixbrl0242"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="Fact000010">F-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="Fact000011">K WAVE MEDIA LTD.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-01-01to2024-12-31" id="Fact000012">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="From2024-01-01to2024-12-31" id="Fact000013">121 South Church Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2024-01-01to2024-12-31" id="Fact000014">George Town</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2024-01-01to2024-12-31" id="Fact000015">Grand Cayman</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="From2024-01-01to2024-12-31" id="Fact000016">KY1-1104</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="From2024-01-01to2024-12-31" id="Fact000017">KY</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="From2024-01-01to2024-12-31" id="Fact000018">703</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-01-01to2024-12-31" id="Fact000019">790-0717</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000020">Cogency Global Inc.</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000021">122 East 42nd Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000022">18th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000023">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000024">NY</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000025">10168</dei:EntityAddressPostalZipCode>
    <dei:CountryRegion
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000026">+1</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000027">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="From2024-01-012024-12-31_dei_BusinessContactMember"
      id="Fact000028">221-0102</dei:LocalPhoneNumber>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-01-01to2024-12-31" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2024-01-01to2024-12-31" id="Fact000030">false</dei:EntityExTransitionPeriod>
    <kwm:OtherReceivablesRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000035"
      unitRef="USD">50000</kwm:OtherReceivablesRelatedParties>
    <kwm:OtherReceivablesRelatedParties
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000036"
      unitRef="USD">50000</kwm:OtherReceivablesRelatedParties>
    <ifrs-full:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000038"
      unitRef="USD">50000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000039"
      unitRef="USD">50000</ifrs-full:Assets>
    <ifrs-full:OtherPayables
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000044"
      unitRef="USD">7256</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000045"
      unitRef="USD">7256</ifrs-full:OtherPayables>
    <kwm:OtherPayablesRelatedParties
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000047"
      unitRef="USD">5551</kwm:OtherPayablesRelatedParties>
    <kwm:OtherPayablesRelatedParties
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000048"
      unitRef="USD">5551</kwm:OtherPayablesRelatedParties>
    <ifrs-full:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000050"
      unitRef="USD">12807</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000051"
      unitRef="USD">12807</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000056"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000057"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:OtherReserves
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">-1376</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000060"
      unitRef="USD">-1376</ifrs-full:OtherReserves>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000062"
      unitRef="USD">-11431</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000063"
      unitRef="USD">-11431</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">37193</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000066"
      unitRef="USD">37193</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000068"
      unitRef="USD">50000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">50000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000078"
      unitRef="USD">11431</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OperatingExpense
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000081"
      unitRef="USD">11431</ifrs-full:OperatingExpense>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000084"
      unitRef="USD">-11431</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000087"
      unitRef="USD">-11431</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000090"
      unitRef="USD">-11431</ifrs-full:ComprehensiveIncome>
    <kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasic
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000092"
      unitRef="Shares">5000000</kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasic>
    <kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingDiluted
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000094"
      unitRef="Shares">5000000</kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingDiluted>
    <kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasic
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000096"
      unitRef="Shares">5000000</kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingBasic>
    <kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingDiluted
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000098"
      unitRef="Shares">5000000</kwm:WeightedAverageNumberOfSharesOfCommonStockOutstandingDiluted>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000104"
      unitRef="USDPShares">-0.002</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000106"
      unitRef="USDPShares">-0.002</ifrs-full:DilutedEarningsLossPerShare>
    <kwm:SharesIssuedForRelatedPartyReceivableShare
      contextRef="From2023-06-222023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000120"
      unitRef="Shares">5000000</kwm:SharesIssuedForRelatedPartyReceivableShare>
    <kwm:SharesIssuedForRelatedPartyReceivable
      contextRef="From2023-06-222023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000115"
      unitRef="USD">50000</kwm:SharesIssuedForRelatedPartyReceivable>
    <kwm:SharesIssuedForRelatedPartyReceivable
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000118"
      unitRef="USD">50000</kwm:SharesIssuedForRelatedPartyReceivable>
    <kwm:OtherReserve
      contextRef="From2023-06-222023-12-31_ifrs-full_OtherReservesMember"
      decimals="0"
      id="Fact000123"
      unitRef="USD">-1376</kwm:OtherReserve>
    <kwm:OtherReserve
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000125"
      unitRef="USD">-1376</kwm:OtherReserve>
    <ifrs-full:ProfitLoss
      contextRef="From2023-06-222023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000129"
      unitRef="USD">-11431</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000130"
      unitRef="USD">-11431</ifrs-full:ProfitLoss>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000137"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000132"
      unitRef="USD">50000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_OtherReservesMember"
      decimals="0"
      id="Fact000133"
      unitRef="USD">-1376</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000134"
      unitRef="USD">-11431</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000135"
      unitRef="USD">37193</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000144"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000139"
      unitRef="USD">50000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_OtherReservesMember"
      decimals="0"
      id="Fact000140"
      unitRef="USD">-1376</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000141"
      unitRef="USD">-11431</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000142"
      unitRef="USD">37193</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000151"
      unitRef="USD">50000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_OtherReservesMember"
      decimals="0"
      id="Fact000152"
      unitRef="USD">-1376</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000153"
      unitRef="USD">-11431</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000154"
      unitRef="USD">37193</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000162"
      unitRef="USD">-11431</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000171"
      unitRef="USD">7257</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables>
    <kwm:IncreaseDecreaseInOtherPayablesRelatedPartiesOtherPayablesRelatedParties
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000174"
      unitRef="USD">4174</kwm:IncreaseDecreaseInOtherPayablesRelatedPartiesOtherPayablesRelatedParties>
    <kwm:DisclosureOfGeneralInformation contextRef="From2024-01-01to2024-12-31" id="Fact000197">&lt;p id="xdx_80A_ecustom--DisclosureOfGeneralInformation_zAJJXZlu1qBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;1. &lt;span id="xdx_828_zCQrNva1oZfj"&gt;General Information&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;K Wave Media Ltd. (&#x201c;the Company&#x201d;), a wholly-owned subsidiary of Global Star Acquisition Inc. (&#x201c;Global Star&#x201d;), was incorporated on June&#160;22, 2023 and the Company&#x2019;s registered office is at c/o Maples Corporate Services Limited, PO Box 309, Ugland House Grand Cayman, KY1-1104 Cayman Islands. The Company was formed for the purpose of becoming the ultimate parent company following the transactions contemplated in the Merger Agreement. The Company maintains one direct wholly owned subsidiary, GLST Merger Sub Inc. (&#x201c;Merger Sub&#x201d;), a Delaware corporation. Merger Sub was incorporated to facilitate the consummation of the Business Combination. As of December 31, 2024, Merger Sub had no operations. The Company and Merger Sub are together referred to as the &#x201c;Group&#x201d;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Global Star entered into a merger agreement, dated as of June&#160;15, 2023 and as amended on March&#160;11, 2024, June&#160;28, 2024, and July&#160;25, 2024 (the &#x201c;Merger Agreement&#x201d;), which provides for a Business Combination between Global Star and K Enter Holdings, Inc., a Delaware corporation (&#x201c;K Enter&#x201d;). Pursuant to the Merger Agreement, the Business Combination will be effected in two steps: (i) subject to the approval and adoption of the Merger Agreement by the stockholders of Global Star, Global Star will reincorporate to Cayman Islands by merging with and into the Company, with the Company remaining as the surviving publicly traded entity (the &#x201c;Reincorporation Merger&#x201d;); (ii) one (1) business day following the Reincorporation Merger, the Merger Sub will be merged with and into K Enter, resulting in K Enter being a wholly owned subsidiary of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July&#160;13, 2023, the Company and the Merger Sub executed a written Joinder Agreement to become parties to the Merger Agreement to comply with the terms and conditions of the Merger Agreement, accordingly, the Merger Agreement is by and among Global Star, the Company, Merger Sub, and K Enter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December&#160;31, 2024, the Company issued &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_c20241231_pdd" title="Shares issued"&gt;5,000,000&lt;/span&gt; shares of the Company&#x2019;s ordinary shares. Pursuant to the Merger Agreement, the Company expects to cancel all the outstanding &lt;span id="xdx_908_eifrs-full--NumberOfSharesOutstanding_c20241231_pdd" title="Shares outstanding"&gt;5,000,000&lt;/span&gt; shares of the Company&#x2019;s ordinary shares as of the effective date of the Business Combination. In connection with the Reincorporation Merger, the Company expects to issue &lt;span id="xdx_907_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--GlobalStarMember_pdd" title="Ordinary shares"&gt;4,178,790&lt;/span&gt; ordinary shares of the Company to the stockholders of Global Star, Also, pursuant to the Merger Agreement the Company expects to issue a total of 59,000,000 ordinary shares of the Company as consideration for a total of &lt;span id="xdx_909_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_c20240101__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--KEnterMember_pdd" title="Ordinary shares"&gt;189,013&lt;/span&gt; shares of K Enter. &lt;span id="xdx_902_ecustom--SharesOfOutstandingDescribsition_c20240101__20241231_zOHKYor41Ima" title="Shares of outstanding describsition"&gt;This consists of 101,202 shares of outstanding K Enter&#x2019;s common stock, 47,013 shares of K Enter Ordinary Shares to be issued to the owners of the Six Korean Entities pursuant to the equity purchase agreement based on 312.1:1 conversion ratio calculated with a foreign exchange rate of KRW 1,470.00 / USD $1.00, and 40,798 K Wave Ordinary Shares to be issued to the holders of K Enter&#x2019;s Series A Preferred Stock and Series A-1 Preferred Stock based on the conversion of the of K Enter Series A Preferred Stock and Series A-1 Preferred Stock. The total ordinary shares of the Company to be issued to the stockholders of K Enter will be 59,000,000 ordinary shares in connection with the closing of the Business Combination. Following the consummation of all the transactions contemplated by the Business Combination, the total outstanding shares of the Company will be 63,178,790.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February&#160;3, 2025, shareholders of Global Star approved the proposals regarding Merger Agreement on the shareholders&#x2019; meeting. The Merger Agreement was completed on May&#160;13, 2025, and the Company became the surviving publicly-traded entity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</kwm:DisclosureOfGeneralInformation>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000199"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000201"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2024-01-012024-12-31_custom_GlobalStarMember"
      decimals="INF"
      id="Fact000203"
      unitRef="Shares">4178790</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2024-01-012024-12-31_custom_KEnterMember"
      decimals="INF"
      id="Fact000205"
      unitRef="Shares">189013</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <kwm:SharesOfOutstandingDescribsition contextRef="From2024-01-01to2024-12-31" id="Fact000207">This consists of 101,202 shares of outstanding K Enter&#x2019;s common stock, 47,013 shares of K Enter Ordinary Shares to be issued to the owners of the Six Korean Entities pursuant to the equity purchase agreement based on 312.1:1 conversion ratio calculated with a foreign exchange rate of KRW 1,470.00 / USD $1.00, and 40,798 K Wave Ordinary Shares to be issued to the holders of K Enter&#x2019;s Series A Preferred Stock and Series A-1 Preferred Stock based on the conversion of the of K Enter Series A Preferred Stock and Series A-1 Preferred Stock. The total ordinary shares of the Company to be issued to the stockholders of K Enter will be 59,000,000 ordinary shares in connection with the closing of the Business Combination. Following the consummation of all the transactions contemplated by the Business Combination, the total outstanding shares of the Company will be 63,178,790.</kwm:SharesOfOutstandingDescribsition>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="From2024-01-01to2024-12-31" id="Fact000209">&lt;p id="xdx_80F_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zh6G4ZaC8cJ6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;2. &lt;span id="xdx_822_zgfuFsBHKSv4"&gt;Basis of Accounting&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;These consolidated financial statements have been prepared in accordance with the International Financial Reporting Standards (&#x201c;IFRS&#x201d;) issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;), on the historical cost basis, and in the presentation currency USD. All amounts are in actual USD unless otherwise stated. The costs of business operations are paid by K Enter and therefore no accounting transactions have been recorded in 2024. These consolidated financial statements were authorized for issuance by the board of directors on May&#160;14, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The number of shares used to calculate diluted loss per share of common shares attributable to common shareholders is the same as the number of shares used to calculate basic loss per share of common shares attributable to common shareholders for the period presented because there were no potentially dilutive securities outstanding during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The loss per share presented in the statements of operations and comprehensive loss is based on the following for the year ended December&#160;31, 2024 and period from June&#160;22, 2023 (inception) to December&#160;31, 2023:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfNotesToConsolidatedFinancialStatements_zMZYlxfz9w97" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Accounting (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BB_zSFnjxmZZq47" style="display: none; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Schedule of notes to consolidated financial statements&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zQ2Mnx8goshd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20230622__20231231_zRw8fh2pbit" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt; period from&lt;br/&gt; June&#160;22, 2023&lt;br/&gt; (inception) to&lt;br/&gt; December&#160;31,&lt;br/&gt; 2023&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BasicAndDilutedNetLossPerShareAbstract_iB_zsZAQOyA40Il" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left"&gt;Basic and diluted net loss per share:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NumeratorAbstract_i01_zTQB1eiHfLhk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Numerator&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ProfitLoss_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0226"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(11,431&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DenominatorAbstract_i01_zKtl1ycqlhK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Denominator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Basic and diluted weighted average number of shares outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageShares_c20240101__20241231_pdd" title="Basic weighted average number of shares outstanding"&gt;&lt;span id="xdx_90F_ecustom--DilutedWeightedAverageNumberOfSharesOutstanding_c20240101__20241231_zU9QnJoyWQX" title="Diluted weighted average number of shares outstanding"&gt;5,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageShares_c20230622__20231231_pdd" title="Basic weighted average number of shares outstanding"&gt;&lt;span id="xdx_90F_ecustom--DilutedWeightedAverageNumberOfSharesOutstanding_c20230622__20231231_pdd" title="Diluted weighted average number of shares outstanding"&gt;5,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted net loss per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--BasicEarningsLossPerShare_c20240101__20241231_zdXJr4AY0jP7" title="Basic net loss per share"&gt;&lt;span id="xdx_90C_eifrs-full--DilutedEarningsLossPerShare_c20240101__20241231_zzyOI5yWuToi" title="diluted net loss per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0240"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0242"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--BasicEarningsLossPerShare_c20230622__20231231_zahhDzr0FH2j" title="Basic net loss per share"&gt;&lt;span id="xdx_900_eifrs-full--DilutedEarningsLossPerShare_c20230622__20231231_zWqYc7NJjZj7" title="diluted net loss per share"&gt;(0.002&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <kwm:ScheduleOfNotesToConsolidatedFinancialStatements contextRef="From2024-01-01to2024-12-31" id="Fact000218">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--ScheduleOfNotesToConsolidatedFinancialStatements_zMZYlxfz9w97" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Basis of Accounting (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td id="xdx_8BB_zSFnjxmZZq47" style="display: none; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Schedule of notes to consolidated financial statements&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_490_20240101__20241231_zQ2Mnx8goshd" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49E_20230622__20231231_zRw8fh2pbit" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt; period from&lt;br/&gt; June&#160;22, 2023&lt;br/&gt; (inception) to&lt;br/&gt; December&#160;31,&lt;br/&gt; 2023&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--BasicAndDilutedNetLossPerShareAbstract_iB_zsZAQOyA40Il" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-style: italic; text-align: left"&gt;Basic and diluted net loss per share:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--NumeratorAbstract_i01_zTQB1eiHfLhk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Numerator&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ProfitLoss_i01_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; width: 76%; text-align: left"&gt;Allocation of net loss&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0226"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;(11,431&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--DenominatorAbstract_i01_zKtl1ycqlhK5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"&gt;Denominator:&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left; padding-bottom: 1pt"&gt;Basic and diluted weighted average number of shares outstanding&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--WeightedAverageShares_c20240101__20241231_pdd" title="Basic weighted average number of shares outstanding"&gt;&lt;span id="xdx_90F_ecustom--DilutedWeightedAverageNumberOfSharesOutstanding_c20240101__20241231_zU9QnJoyWQX" title="Diluted weighted average number of shares outstanding"&gt;5,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--WeightedAverageShares_c20230622__20231231_pdd" title="Basic weighted average number of shares outstanding"&gt;&lt;span id="xdx_90F_ecustom--DilutedWeightedAverageNumberOfSharesOutstanding_c20230622__20231231_pdd" title="Diluted weighted average number of shares outstanding"&gt;5,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.25in; text-align: left"&gt;Basic and diluted net loss per share&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--BasicEarningsLossPerShare_c20240101__20241231_zdXJr4AY0jP7" title="Basic net loss per share"&gt;&lt;span id="xdx_90C_eifrs-full--DilutedEarningsLossPerShare_c20240101__20241231_zzyOI5yWuToi" title="diluted net loss per share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0240"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0242"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--BasicEarningsLossPerShare_c20230622__20231231_zahhDzr0FH2j" title="Basic net loss per share"&gt;&lt;span id="xdx_900_eifrs-full--DilutedEarningsLossPerShare_c20230622__20231231_zWqYc7NJjZj7" title="diluted net loss per share"&gt;(0.002&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</kwm:ScheduleOfNotesToConsolidatedFinancialStatements>
    <ifrs-full:ProfitLoss
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000227"
      unitRef="USD">-11431</ifrs-full:ProfitLoss>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000232"
      unitRef="Shares">5000000</ifrs-full:WeightedAverageShares>
    <kwm:DilutedWeightedAverageNumberOfSharesOutstanding
      contextRef="From2024-01-01to2024-12-31"
      decimals="INF"
      id="Fact000234"
      unitRef="Shares">5000000</kwm:DilutedWeightedAverageNumberOfSharesOutstanding>
    <ifrs-full:WeightedAverageShares
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000236"
      unitRef="Shares">5000000</ifrs-full:WeightedAverageShares>
    <kwm:DilutedWeightedAverageNumberOfSharesOutstanding
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000238"
      unitRef="Shares">5000000</kwm:DilutedWeightedAverageNumberOfSharesOutstanding>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000244"
      unitRef="USDPShares">-0.002</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2023-06-222023-12-31"
      decimals="INF"
      id="Fact000246"
      unitRef="USDPShares">-0.002</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory contextRef="From2024-01-01to2024-12-31" id="Fact000248">&lt;p id="xdx_803_eifrs-full--DisclosureOfChangesInAccountingPoliciesExplanatory_z4sJHNa0SXF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;3. &lt;span id="xdx_822_zesKXW2vH19e"&gt;Material accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The material accounting policies followed by the Group in preparation of its financial statements are as follows:.&lt;/p&gt;



&lt;p id="xdx_842_eifrs-full--DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_zrcpyuDmw2a1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_862_zUisOJXmcYCl"&gt;New and amended standards or interpretations adopted by the Company&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IAS 1 Presentation of Financial Statements - Classification of Liabilities as Current or Non-current&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments to IAS 1 clarify that liabilities are classified as either current or non-current, depending on the substantive rights that exist at the end of the reporting period. Classification is unaffected by the likelihood that an entity will exercise right to defer settlement of the liability or the expectations of management. Also, the settlement of liability includes the transfer of the entity&#x2019;s own equity instruments, however, it would be excluded if an option to settle them by the entity&#x2019;s own equity instruments if compound financial instruments is met the definition of equity instruments and recognized separately from the liability. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IAS 7 Statement of Cash Flows - IFRS 7 Financial Instruments: Disclosures &#x2013; Supplier finance arrangements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments to IAS 7 require entity to disclose information about its supplier finance arrangements that enables users of financial statements to assess the effects of those arrangements on the entity&#x2019;s liabilities and cash flows and on the entity&#x2019;s exposure to liquidity risk when applying supplier finance arrangements. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 16 &#x2013; Lease Liability in a Sale and Leaseback&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments to IFRS 16 require a seller-lessee shall determine lease payments or revised lease payments in a way that the seller-lessee would not recognize any amount of the gain or loss that relates to the right of use retained by the seller-lessee when subsequently measuring lease liabilities arising from a sale and leaseback. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;



&lt;p id="xdx_846_eifrs-full--DescriptionOfInitialApplicationOfStandardsOrInterpretations_zLz0OxkSHkSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_864_zK2UT2EmO0eh"&gt;New and amended standards or interpretations not yet adopted by the Company&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The following new accounting standards and interpretations that have been published that are not mandatory for December&#160;31, 2024 reporting periods and have not been early adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IAS 21 The Effects of Changes in Foreign Exchange Rates &#x2013; Lack of Exchangeability&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments require exchangeability of two currencies should be assessed in order to clarify reporting of foreign currency transactions in the absence of normal-functioning foreign exchange market. The amendments also require applicable spot exchange rate should be determined when the assessment indicates two currencies lack exchangeability. The amendments are effective for annual reporting periods beginning on or after January&#160;1, 2025, with early application permitted. The Company does not expect that these amendments have a significant impact on the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 9 Financial Instruments - IFRS 7 Financial Instruments: Disclosures &#x2013; Classification and Measurement of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments clarify that a financial liability is derecognised on the &#x2018;settlement date&#x2019; and introduce an accounting policy choice to derecognise financial liabilities settled using an electronic payment system before the settlement date. Other clarifications include the classification of financial assets with ESG linked features via additional guidance on the assessment of contingent features. Clarifications have been made to non-recourse loans and contractually linked instruments. Additional disclosures are introduced for financial instruments with contingent features and equity instruments classified at fair value through OCI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments should be applied for annual periods beginning on or after January&#160;1, 2026, and earlier application is permitted, with an option to early adopt the amendments for contingent features only. The Company does not expect that these amendments have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Annual Improvements to IFRS Accounting Standards &#x2013; Volume 11&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments are annual improvements to the following standards:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 1 First-time adoption of International Financial Reporting Standards;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 7 Financial instruments: Disclosures;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 9 Financial instruments;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 10 Consolidated financial instruments; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IAS 7 Statement of cash flows&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The new standard should be applied for annual periods beginning on or after January&#160;1, 2026, and earlier application is permitted. The Company is in review for the impact of this new standard on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 18 Presentation and Disclosure in Financial Statements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;Items in the statement of profit or loss will need to be classified into one of five categories: operating, investing, financing, income taxes and discontinued operations. IFRS 18 requires the Company to present specified totals and subtotals: &#x2018;Operating profit or loss&#x2019;, &#x2018;Profit or loss&#x2019; and &#x2018;Profit or loss before financing and income taxes&#x2019;. Information related to management-defined performance measures should be disclosed. IFRS 18 also provides enhanced guidance on the principles of aggregation and disaggregation which focus on grouping items based on their shared characteristics. The new standard should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company is in review for the impact of this new standard on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 19 Subsidiaries without Public Accountability: Disclosures&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;IFRS 19 allows eligible subsidiaries to apply IFRS Accounting Standards with the reduced disclosure requirements of IFRS 19. A subsidiary may choose to apply the new standard in its consolidated, separate or individual financial statements provided that, at the reporting date, it does not have public accountability, and its parent produces consolidated financial statements under IFRS Accounting Standards. A subsidiary applying IFRS 19 is required to disclose in its explicit and unreserved statements of compliance with IFRS Accounting Standards that IFRS 19 has been adopted. The amendments should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company does not expect that these amendments have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;































&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForRecognisingDifferenceBetweenFairValueAtInitialRecognitionAndAmountDeterminedUsingValuationTechniqueExplanatory_zswT8tRKXLdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_867_zHr5phFl0Ry6"&gt;Financial assets and Financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;Financial instruments are any form of contract that gives rise to a financial asset in one company and a financial liability or equity instrument in another company. A financial asset or financial liability is included in the balance sheet when the entity becomes a party to the contractual terms of the instrument. Other financial liabilities and other financial assets, including liabilities to and receivables from related parties, are valued at amortized cost. A financial asset is removed from the balance sheet when the contractual right to cash flow from the asset has ceased or been settled. The same applies where the risks and benefits associated with the holding are essentially transferred to another party and the entity no longer has control over the financial asset. A financial liability is derecognized when the agreed obligation has been fulfilled or ceased.&lt;/p&gt;



&lt;p id="xdx_84E_ecustom--DescriptionOTransactionCostsInIssuingEquitySecuritiesOrganizationCostsAndOtherServiceFees_zGuVGBsJLZp9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_863_zO31YTHTQtbi"&gt;Transaction costs in issuing equity securities, organization costs, and other service fees&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;When issuing common stock, incremental costs directly attributable to the equity transaction that otherwise would have been avoided are accounted for as a deduction from equity while other issuing related costs and organization costs are expensed as incurred. For the period from June&#160;22, 2023 (inception) to December&#160;31, 2023, $&lt;span id="xdx_90F_eifrs-full--OtherReserves_iNI_pp0p0_di_c20231231_z0O9JjlEHgue" title="Other reserves"&gt;1,376&lt;/span&gt; was deducted from equity while $&lt;span id="xdx_904_ecustom--TransactionCosts_pp0p0_c20230622__20231231_zdqLggfhdzQ" title="Transaction costs"&gt;3,882&lt;/span&gt; was expensed as incurred. $&lt;span id="xdx_906_ecustom--ServiceFeesExpensed_pp0p0_c20230622__20231231_ziOZKehLPFNh" title="Service fees expensed"&gt;7,549&lt;/span&gt; service fees were expensed as incurred. $&lt;span id="xdx_908_ecustom--OtherPayablesRelatedParties_iI_c20231231_zTPM94h7pgra" title="Other payables - related parties"&gt;5,551&lt;/span&gt; is owed to Global Star and recorded as a payable under the caption Other payables - related parties in the Group&#x2019;s Consolidated Statement of Financial Position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations contextRef="From2024-01-01to2024-12-31" id="Fact000250">&lt;p id="xdx_842_eifrs-full--DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_zrcpyuDmw2a1" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;A.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_862_zUisOJXmcYCl"&gt;New and amended standards or interpretations adopted by the Company&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IAS 1 Presentation of Financial Statements - Classification of Liabilities as Current or Non-current&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments to IAS 1 clarify that liabilities are classified as either current or non-current, depending on the substantive rights that exist at the end of the reporting period. Classification is unaffected by the likelihood that an entity will exercise right to defer settlement of the liability or the expectations of management. Also, the settlement of liability includes the transfer of the entity&#x2019;s own equity instruments, however, it would be excluded if an option to settle them by the entity&#x2019;s own equity instruments if compound financial instruments is met the definition of equity instruments and recognized separately from the liability. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IAS 7 Statement of Cash Flows - IFRS 7 Financial Instruments: Disclosures &#x2013; Supplier finance arrangements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments to IAS 7 require entity to disclose information about its supplier finance arrangements that enables users of financial statements to assess the effects of those arrangements on the entity&#x2019;s liabilities and cash flows and on the entity&#x2019;s exposure to liquidity risk when applying supplier finance arrangements. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 16 &#x2013; Lease Liability in a Sale and Leaseback&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments to IFRS 16 require a seller-lessee shall determine lease payments or revised lease payments in a way that the seller-lessee would not recognize any amount of the gain or loss that relates to the right of use retained by the seller-lessee when subsequently measuring lease liabilities arising from a sale and leaseback. The amendments do not have a significant impact on the financial statements.&lt;/p&gt;



</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations contextRef="From2024-01-01to2024-12-31" id="Fact000252">&lt;p id="xdx_846_eifrs-full--DescriptionOfInitialApplicationOfStandardsOrInterpretations_zLz0OxkSHkSd" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;B.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_864_zK2UT2EmO0eh"&gt;New and amended standards or interpretations not yet adopted by the Company&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The following new accounting standards and interpretations that have been published that are not mandatory for December&#160;31, 2024 reporting periods and have not been early adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

































&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IAS 21 The Effects of Changes in Foreign Exchange Rates &#x2013; Lack of Exchangeability&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments require exchangeability of two currencies should be assessed in order to clarify reporting of foreign currency transactions in the absence of normal-functioning foreign exchange market. The amendments also require applicable spot exchange rate should be determined when the assessment indicates two currencies lack exchangeability. The amendments are effective for annual reporting periods beginning on or after January&#160;1, 2025, with early application permitted. The Company does not expect that these amendments have a significant impact on the Company&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 9 Financial Instruments - IFRS 7 Financial Instruments: Disclosures &#x2013; Classification and Measurement of Financial Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments clarify that a financial liability is derecognised on the &#x2018;settlement date&#x2019; and introduce an accounting policy choice to derecognise financial liabilities settled using an electronic payment system before the settlement date. Other clarifications include the classification of financial assets with ESG linked features via additional guidance on the assessment of contingent features. Clarifications have been made to non-recourse loans and contractually linked instruments. Additional disclosures are introduced for financial instruments with contingent features and equity instruments classified at fair value through OCI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments should be applied for annual periods beginning on or after January&#160;1, 2026, and earlier application is permitted, with an option to early adopt the amendments for contingent features only. The Company does not expect that these amendments have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Annual Improvements to IFRS Accounting Standards &#x2013; Volume 11&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The amendments are annual improvements to the following standards:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 1 First-time adoption of International Financial Reporting Standards;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 7 Financial instruments: Disclosures;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 9 Financial instruments;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IFRS 10 Consolidated financial instruments; and&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;-&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;IAS 7 Statement of cash flows&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;The new standard should be applied for annual periods beginning on or after January&#160;1, 2026, and earlier application is permitted. The Company is in review for the impact of this new standard on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 18 Presentation and Disclosure in Financial Statements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;Items in the statement of profit or loss will need to be classified into one of five categories: operating, investing, financing, income taxes and discontinued operations. IFRS 18 requires the Company to present specified totals and subtotals: &#x2018;Operating profit or loss&#x2019;, &#x2018;Profit or loss&#x2019; and &#x2018;Profit or loss before financing and income taxes&#x2019;. Information related to management-defined performance measures should be disclosed. IFRS 18 also provides enhanced guidance on the principles of aggregation and disaggregation which focus on grouping items based on their shared characteristics. The new standard should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company is in review for the impact of this new standard on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;IFRS 19 Subsidiaries without Public Accountability: Disclosures&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;IFRS 19 allows eligible subsidiaries to apply IFRS Accounting Standards with the reduced disclosure requirements of IFRS 19. A subsidiary may choose to apply the new standard in its consolidated, separate or individual financial statements provided that, at the reporting date, it does not have public accountability, and its parent produces consolidated financial statements under IFRS Accounting Standards. A subsidiary applying IFRS 19 is required to disclose in its explicit and unreserved statements of compliance with IFRS Accounting Standards that IFRS 19 has been adopted. The amendments should be applied for annual periods beginning on or after January&#160;1, 2027, and earlier application is permitted. The Company does not expect that these amendments have a significant impact on the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;































</ifrs-full:DescriptionOfInitialApplicationOfStandardsOrInterpretations>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognisingDifferenceBetweenFairValueAtInitialRecognitionAndAmountDeterminedUsingValuationTechniqueExplanatory contextRef="From2024-01-01to2024-12-31" id="Fact000267">&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForRecognisingDifferenceBetweenFairValueAtInitialRecognitionAndAmountDeterminedUsingValuationTechniqueExplanatory_zswT8tRKXLdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;C.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_867_zHr5phFl0Ry6"&gt;Financial assets and Financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;Financial instruments are any form of contract that gives rise to a financial asset in one company and a financial liability or equity instrument in another company. A financial asset or financial liability is included in the balance sheet when the entity becomes a party to the contractual terms of the instrument. Other financial liabilities and other financial assets, including liabilities to and receivables from related parties, are valued at amortized cost. A financial asset is removed from the balance sheet when the contractual right to cash flow from the asset has ceased or been settled. The same applies where the risks and benefits associated with the holding are essentially transferred to another party and the entity no longer has control over the financial asset. A financial liability is derecognized when the agreed obligation has been fulfilled or ceased.&lt;/p&gt;



</ifrs-full:DescriptionOfAccountingPolicyForRecognisingDifferenceBetweenFairValueAtInitialRecognitionAndAmountDeterminedUsingValuationTechniqueExplanatory>
    <kwm:DescriptionOTransactionCostsInIssuingEquitySecuritiesOrganizationCostsAndOtherServiceFees contextRef="From2024-01-01to2024-12-31" id="Fact000269">&lt;p id="xdx_84E_ecustom--DescriptionOTransactionCostsInIssuingEquitySecuritiesOrganizationCostsAndOtherServiceFees_zGuVGBsJLZp9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0in; text-align: right; vertical-align: top"&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top"&gt;&lt;b&gt;D.&lt;/b&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;span id="xdx_863_zO31YTHTQtbi"&gt;Transaction costs in issuing equity securities, organization costs, and other service fees&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;When issuing common stock, incremental costs directly attributable to the equity transaction that otherwise would have been avoided are accounted for as a deduction from equity while other issuing related costs and organization costs are expensed as incurred. For the period from June&#160;22, 2023 (inception) to December&#160;31, 2023, $&lt;span id="xdx_90F_eifrs-full--OtherReserves_iNI_pp0p0_di_c20231231_z0O9JjlEHgue" title="Other reserves"&gt;1,376&lt;/span&gt; was deducted from equity while $&lt;span id="xdx_904_ecustom--TransactionCosts_pp0p0_c20230622__20231231_zdqLggfhdzQ" title="Transaction costs"&gt;3,882&lt;/span&gt; was expensed as incurred. $&lt;span id="xdx_906_ecustom--ServiceFeesExpensed_pp0p0_c20230622__20231231_ziOZKehLPFNh" title="Service fees expensed"&gt;7,549&lt;/span&gt; service fees were expensed as incurred. $&lt;span id="xdx_908_ecustom--OtherPayablesRelatedParties_iI_c20231231_zTPM94h7pgra" title="Other payables - related parties"&gt;5,551&lt;/span&gt; is owed to Global Star and recorded as a payable under the caption Other payables - related parties in the Group&#x2019;s Consolidated Statement of Financial Position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</kwm:DescriptionOTransactionCostsInIssuingEquitySecuritiesOrganizationCostsAndOtherServiceFees>
    <ifrs-full:OtherReserves
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000271"
      unitRef="USD">-1376</ifrs-full:OtherReserves>
    <kwm:TransactionCosts
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000273"
      unitRef="USD">3882</kwm:TransactionCosts>
    <kwm:ServiceFeesExpensed
      contextRef="From2023-06-222023-12-31"
      decimals="0"
      id="Fact000275"
      unitRef="USD">7549</kwm:ServiceFeesExpensed>
    <kwm:OtherPayablesRelatedParties
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000277"
      unitRef="USD">5551</kwm:OtherPayablesRelatedParties>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="From2024-01-01to2024-12-31" id="Fact000279">&lt;p id="xdx_80A_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z4K8ZM4dZvZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;4. &lt;span id="xdx_824_zty3Pv7XZXQ5"&gt;Share capital&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Details of share capital as of December&#160;31, 2024 and 2023 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfShareCapital_zHQhNDw15AK1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr&gt;
    &lt;td id="xdx_8B1_zqyuM9c46yYi" style="display: none; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Schedule of share capital&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231_z5KIvwgqj7Ic" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20231231_zwB1dKXZ51oj" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--NumberOfSharesAuthorised_iI_pdd" style="background-color: #CFF0FC"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; width: 76%"&gt;&lt;span style="font-size: 10pt"&gt;Number of authorized shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 9%"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 9%"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ParValuePerShare_iI_pdd"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Value per share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NumberOfSharesIssued_iI_pdd" style="background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Number of shares issued&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IssuedCapital_iI_pp0p0"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Common shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During June&#160;2023, the Group entered into an agreement to issue &lt;span id="xdx_902_eifrs-full--IncreaseDecreaseInNumberOfOrdinarySharesIssued_c20230601__20230630_pdd" title="Number of shares issued"&gt;5,000,000&lt;/span&gt; shares of common shares for gross proceeds of $&lt;span id="xdx_906_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20230601__20230630_pp0p0" title="Gross proceeds form shares issued"&gt;50,000&lt;/span&gt;. &lt;span id="xdx_900_ecustom--VotingRights_c20230601__20230630_z5enqM8uU7m2" title="Voting rights"&gt;Each ordinary share maintains one voting right. &lt;/span&gt;The entire amount of this equity is held by Global Star and recorded as a receivable under the caption Other receivables - related parties in the Group&#x2019;s Consolidated Statements of Financial Position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;



</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <kwm:ScheduleOfShareCapital contextRef="From2024-01-01to2024-12-31" id="Fact000281">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfShareCapital_zHQhNDw15AK1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Share capital (Details)"&gt;
  &lt;tr&gt;
    &lt;td id="xdx_8B1_zqyuM9c46yYi" style="display: none; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;Schedule of share capital&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20241231_z5KIvwgqj7Ic" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_498_20231231_zwB1dKXZ51oj" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;December&#160;31,&lt;br/&gt; 2024&lt;/b&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December&#160;31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--NumberOfSharesAuthorised_iI_pdd" style="background-color: #CFF0FC"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; width: 76%"&gt;&lt;span style="font-size: 10pt"&gt;Number of authorized shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 9%"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 9%"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--ParValuePerShare_iI_pdd"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Value per share&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;0.01&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NumberOfSharesIssued_iI_pdd" style="background-color: #CCEEFF"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Number of shares issued&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IssuedCapital_iI_pp0p0"&gt;
    &lt;td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Common shares&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;50,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</kwm:ScheduleOfShareCapital>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000283"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:NumberOfSharesAuthorised
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000284"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000286"
      unitRef="USDPShares">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000287"
      unitRef="USDPShares">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000289"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2023-12-31"
      decimals="INF"
      id="Fact000290"
      unitRef="Shares">5000000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000292"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000293"
      unitRef="USD">50000</ifrs-full:IssuedCapital>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued
      contextRef="From2023-06-012023-06-30"
      decimals="INF"
      id="Fact000295"
      unitRef="Shares">5000000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2023-06-012023-06-30"
      decimals="0"
      id="Fact000297"
      unitRef="USD">50000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <kwm:VotingRights contextRef="From2023-06-012023-06-30" id="Fact000299">Each ordinary share maintains one voting right.</kwm:VotingRights>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="From2024-01-01to2024-12-31" id="Fact000301">&lt;p id="xdx_806_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zVhcTWwxYYUd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;5. &lt;span id="xdx_824_zJNm2qjLVLPl"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;During January&#160;2025, the Company entered into agreements with five investors to issue Convertible Senior Unsecured Notes (principal amount $&lt;span id="xdx_90D_ecustom--PrincipalAmount_iI_pn3n3_dm_c20250131__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FiveInvestorsMember_zvB5aL2SijFg" title="Principal amount"&gt;4.5&lt;/span&gt; million), contingent upon the consummation of the business combination. The agreements include various terms and conditions, including the issuance of bonus shares by the Company and &lt;span id="xdx_900_eifrs-full--BorrowingsMaturity_dtY_c20250101__20250131__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FiveInvestorsMember_zQe20csAWlka" title="Maturity term"&gt;3-year&lt;/span&gt; maturity with &lt;span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_dp_c20250131__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FiveInvestorsMember_zAY1z6SE43i3" title="Annual coupon rate"&gt;3%&lt;/span&gt; annual coupon rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On February&#160;3, 2025, shareholders of Global Star approved the proposals regarding Merger Agreement on the shareholders&#x2019; meeting. The Merger Agreement was completed on May&#160;13, 2025.&lt;/p&gt;



</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <kwm:PrincipalAmount
      contextRef="AsOf2025-01-31_custom_FiveInvestorsMember"
      decimals="-3"
      id="Fact000303"
      unitRef="USD">4500000</kwm:PrincipalAmount>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2025-01-012025-01-31_custom_FiveInvestorsMember"
      id="Fact000305">3-year</ifrs-full:BorrowingsMaturity>
    <ifrs-full:BorrowingsInterestRate
      contextRef="AsOf2025-01-31_custom_FiveInvestorsMember"
      decimals="INF"
      id="Fact000307"
      unitRef="Pure">0.03</ifrs-full:BorrowingsInterestRate>
</xbrl>
